Among these, CXCL9 is a chemokine that plays a crucial role in recruiting specific immune cell populations (T cells and natural killer cells) to sites of inflammation, promoting chronic inflammation and immune-mediated tissue damage, which could be a biomarker for NASH and IBD54,55. The gene discussed is CXCL9; the disease is metabolic dysfunction-associated steatohepatitis.